They further found that locked nucleic acid (LNA)–modified inhibitor of miR-192 dramatically increased Zeb1/2 expression and reduced the level of collagen, TGF-b, and fibronectin, therefore alleviating DN. This evidence concerns the gene ZEB1 and liver dysplastic nodule.